FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> FDA   Phase III   Phase II   Cancer Drugs
Syndicate content

combination News

Most Popular combination Story

Vertex shares rise on positive data for telaprevir

Vertex Pharmaceuticals saw a significant bump in its share price this morning after researchers released new, mid-stage interim data backing telaprevir for hepatitis C. The company is now penciling Read more...

Latest Headlines